Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Two new purpose-built facilities at the CDMO’s headquarters are part of an ongoing global expansion investment that now totals over $500 million.
March 6, 2024
By: Tim Wright
The Almac Group has announced the completion of two new purpose-built facilities at its headquarters in Craigavon, Northern Ireland meeting client demand in commercial manufacturing and packaging as well as peptide production. The multi-million-dollar large-scale expansion grows operations for two of the group’s business units, Almac Pharma Services and Almac Sciences. The first of these two major projects is a 32,000 square foot custom-built high-volume facility for Almac Pharma Services that increases commercial manufacturing and packaging of sachet drug product presentations. The investment includes additional large-scale manufacturing suites, automated primary and secondary sachet packaging technologies and also expands the company’s QC laboratory testing capacity. The second project is a 28,000 square foot GMP facility that more than doubles peptide API manufacturing capacity for Almac Sciences. It will enhance synthesis, purification and isolation capabilities and meet anticipated demand for clinical development and commercial products. These new developments are part of Almac’s global investment program announced in June 2022. Since the start of the program Almac has also announced a Center of Excellence for Commercial Drug Product Partnership; a CDx Development, Manufacturing and Commercial Center; a drug substance GMP facility for clinical and commercial manufacturing; further expansion to clinical production and distribution capabilities in Souderton, PA and the launch of cryogenic and ultra-low service capabilities for clinical supply in Durham, NC. Graeme McBurney, Chief Operating Officer, Almac Group, said, “Today’s announcement of continued expansion ensures that we remain the global leaders in our industry, giving our clients and ultimately patients across the world who benefit from these therapeutics, the best possible offering from Almac. Our new peptide API manufacturing facility will significantly grow our portfolio of client APIs and is the latest stage of a wider development and manufacturing expansion initiative for Almac Sciences. The business has also recently opened a new technology development centre, installed additional small molecule API GMP reactors, and opened a dedicated chemical warehouse. In the drug product service arm of our business, Almac Pharma Services is adding to its large-scale commercial manufacturing and packaging capabilities in response to growing demand for tailored solutions to meet clients’ market growth needs. This allows us to support our clients throughout a drug’s lifespan, from early development through to commercialisation. Almac Group believes it is vital to keep growing our capacity and our range of service offerings to meet the growing needs of all our clients now and into the future. I am extremely proud of the strong, global reputation that Almac has built over the last 55 years as a trusted and stable CDMO partner for the world’s leading biopharma companies.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !